Abstract 2046P
Background
Effective communication between doctors and patients is crucial, especially when delivering bad news that can impact a person's present and future expectations. However, acquiring optimal skills in breaking bad news requires the incorporation of multiple professional competencies that are acquired gradually through years of training. The purpose of this study was to conduct a systematic review of existing literature on medical education programs and interventions aiming to improve communication skills and to critically evaluate the effectiveness of such training.
Methods
We conducted a systematic review following PRISMA guidelines, searching PubMed and Scopus databases at February 2023, using the key words “medical education,” “breaking bad news,” and “end of life communication.”
Results
Our search yielded 21 relevant studies, with 12 randomized studies indicating improvements in trainees found in PubMed, while four Scopus studies referred to workshops and seminars that increased participants' confidence in various communication areas. Furthermore, eight studies referred to training courses on communication techniques that helped medical students and health professionals develop confidence in breaking bad news skills. One study utilized interactive theater and role-play with professional actors to teach breaking bad news to medical students, which can be a potentially powerful tool for teaching breaking bad news during medical education. One study showed that the COVID-19 pandemic has disrupted health education due to social distancing.
Conclusions
Our findings suggest that training physicians at the undergraduate and postgraduate levels in communication skills for breaking bad news can be beneficial for both physicians and patients. However, limitations exist in reaching definitive conclusions. As digital learning has emerged in healthcare education during the post-COVID-19 period, digital solutions have also been examined for training in the communication of bad news.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2076P - Topical diclofenac for prevention of HFS in patients receiving capecitabine monotherapy: An exploratory subgroup analysis of the D-ToRCH phase III trial
Presenter: Akhil Santhosh
Session: Poster session 06
2077P - A randomized, placebo-controlled trial assessing the efficacy and safety of the combination of superoxide dismutase, alpha lipoic acid, vitamin B12, B1, B2, B6, E, Mg, Zn and a fatty acid for 6 months in the management of chemotherapy induced neuropathic pain
Presenter: Triantafylos Didangelos
Session: Poster session 06
2078P - Evaluation of chemotherapy-induced nausea and vomiting beyond the delayed phase: Results of a survey of healthcare providers in Japan
Presenter: Florian Scotté
Session: Poster session 06
2079P - Naloxegol for the treatment of opioid-induced constipation in patients with cancer pain: A pooled analysis of real-world studies (NALOPOOL)
Presenter: Maria del Carmen Beato Zambrano
Session: Poster session 06
2080P - Incidence and risks of intravenous chemotherapy-induced neutropenia (ICIN) in oncology: A multicenter retrospective cohort study on real-life data
Presenter: Olivia Rohr
Session: Poster session 06
2081P - The therapeutic effect of anti-inflammatory tripeptide cream on hand-foot syndrome related to anticancer drugs: A prospective, randomized, placebo-controlled pilot trial
Presenter: Yaewon Yang
Session: Poster session 06
2082P - TASMAN: An international survey on the knowledge, aTtitudes and clinical pAtternsS of use of Medical Cannabis for caNcer care
Presenter: Marco Filetti
Session: Poster session 06
2083P - Association between VTE location and risk of recurrent, bleeding and death in the international prospective TESEO SEOM cancer cohort
Presenter: Rocío Martín Lozano
Session: Poster session 06
2084P - Cardiovascular (CV) mortality among metastatic cancer patients: A retrospective cohort study
Presenter: Irbaz Riaz
Session: Poster session 06
2085P - Buprenorphine use and cancer outcomes
Presenter: Nosayaba Osazuwa-Peters
Session: Poster session 06